(5R)-9α-ヒドロキシ-5,8,8aβ,9-テトラヒドロ-5β-(4-ヒドロキシ-3,5-ジメトキシフェニル)フロ[3',4':6,7]ナフト[2,3-d]-1,3-ジオキソール-6(5aαH)-オン

194.83 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]；186.31 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]；196.1 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]；183.67 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Danger

H315 (33.3%): Causes skin irritation [Warning Skin corrosion/irritation]；H319 (33.3%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H340 (33.3%): May cause genetic defects [Danger Germ cell mutagenicity]；H350 (33.3%): May cause cancer [Danger Carcinogenicity]；H360 (33.3%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P264, P264+P265, P280, P302+P352, P305+P351+P338, P318, P321, P332+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.